Chemical Compound

QUINGESTANOL ACETATE

CAS Registry Number 3000-39-3
QUINGESTANOL ACETATE chemical structure
Primary Record

QUINGESTANOL ACETATE

In stock
7,611 g
Purity
99.5 %
CAS
3000-39-3

Compound Identifiers & Properties

CAS
3000-39-3
PubChem CID
18142
SMILES
CC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@H]3CCC(=C4)OC5CCCC5)C)C#C
Canonical SMILES
C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CC=C4C=C(OC5CCCC5)CC[C@@H]4[C@H]3CC[C@@]21C

Names & Synonyms

  • QUINGESTANOL ACETATE
  • QUINGESTANOL
  • Quingestanol acetate [USAN]
  • M33GGZ63KG
  • UNII-M33GGZ63KG
  • AC1L2BFH
  • RefChem:178190
  • 3000-39-3
  • Quingestanol acetate (USAN)
  • SCHEMBL282347
  • DTXSID50952409
  • EINECS 221-078-4
  • W 4540
  • BRN 2186975
  • orb1695550
  • CHEMBL2105291
  • Norethindrone acetate 3-cyclopentyl enol ether
  • CHEBI:135661
  • DTXCID801380499
  • C27H36O3
  • CID18142
  • W-4540
  • QUINGESTANOL ACETATE [WHO-DD]
  • 3-Cyclopentyl enol ether of norethindrone acetate
  • AKOS040753679
  • C27-H36-O3
  • DB14679
  • J7.660K
  • LS-97343
  • NS00047430
  • W4540
  • D05679
  • 3-(Cyclopentyloxy)-19-nor-17alpha-pregna-3,5-dien-20-yn-17-ol acetate
  • (1S,2R)-2-(cyclohexylamino)-1,2-diphenylethanol
  • [(8R,9S,10R,13S,14S,17R)-3-cyclopentyloxy-17-ethynyl-13-methyl-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
  • Q7272228
  • 19-Nor-17-alpha-pregna-3,5-dien-20-yn-17-ol, 3-(cyclopentyloxy)-, acetate (ester)
  • 19-Nor-17-alpha-pregna-3,5-dien-20-yn-17-ol, 3-(cyclopentyloxy)-, acetate
  • 3-(Cyclopentyloxy)-19-nor-17-alpha-pregna-3,5-dien-20-yn-17-ol acetate
  • 3-(Cyclopentyloxy)-19-nor-17alpha-pregna-3,5-dien-20-yn-17-yl acetate
  • 3-19-nor-17alpha-pregna-3,5-dien-20-yn-17-ylacetate
  • 19-Norpregna-3,5-dien-20-yn-17-ol, 3-(cyclopentyloxy)-, acetate, (17alpha)-
  • 3- -19-nor-17alpha-pregna-3,5-dien-20-yn-17-ylacetate
  • 3-(Cyclopentyloxy)-19-nor-17-alpha-pregna-3,5-dien-20-yn-17-ol acetate (ester)
  • 19-Norpregna-3,5-dien-20-yn-17-ol, 3-(cyclopentyloxy)-, acetate, (17.alpha.)-
  • (17R)-3-(Cyclopentyloxy)-19-norpregna-3,5-dien-20-yn-17-ol 17-acetate
  • (17R)-3-Cyclopentyloxy-19-norpregna-3,5-dien-20-yn-17-ol acetate
  • 3-(Cyclopentyloxy)-17alpha-19-norpregna-3,5-dien-20-yn-17-yl acetate
  • 19-Nor-17.alpha.-pregna-3,5-dien-20-yn-17-ol, 3-(cyclopentyloxy)-, acetate
  • (1R,3aS,3bR,9aR,9bS,11aS)-7-(cyclopentyloxy)-1-ethynyl-11a-methyl-1H,2H,3H,3aH,3bH,4H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta(a)phenanthren-1-yl acetate
  • (1R,3aS,3bR,9aR,9bS,11aS)-7-(cyclopentyloxy)-1-ethynyl-11a-methyl-1H,2H,3H,3aH,3bH,4H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl acetate
  • [(8R,9S,10R,13S,14S,17R)-3-Cyclopentyloxy-17-ethynyl-13-methyl-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]acetate
  • 221-078-4